Professor, Urology, Mayo Medical School
Urology
Dr. Stephen A. Boorjian, MD
|
|
Give Review
Dr. Stephen A. Boorjian practices Urology. He attended Harvard Medical School. Harvard Medical School is a top medical university. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. He over the years received 4 awards: "Young Urologist of the Year", "AUA-EAU Academic Exchange Program Scholar", "Teacher of the Year" and "Fellow (FACS)". Stephen A. Boorjian is a published doctor and has 97 publications published. The lastest was: 'Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy.' Dr. Stephen A. Boorjian is registered with Medicare and accepts Medicare payments.
Publications
- Decreased Skeletal Muscle Mass is Associated with an Increased Risk of Mortality after Radical Nephrectomy for Localized Renal Cell Cancer.
- Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes.
- Perioperative management and oncological outcomes following radical cystectomy for Bladder cancer: a matched retrospective cohort study.
- Paraneoplastic syndromes are associated with adverse prognosis among patients with Renal cell carcinoma undergoing nephrectomy.
- Assessing the Optimal Timing for Early Salvage Radiation Therapy in Patients with Prostate-specific Antigen Rise After Radical Prostatectomy.
- A novel prognostic model for patients with sarcomatoid Renal cell carcinoma.
- Long-term results of radical cystectomy and role of adjuvant chemotherapy for small cell carcinoma of the Bladder.
- Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
- The cistrome and gene signature of androgen receptor splice variants in castration resistant prostate Cancer cells.
- Impact of Rhabdoid Differentiation on Prognosis for Patients with Grade 4 Renal Cell Carcinoma.
- Cystectomy for refractory hemorrhagic cystitis: contemporary etiology, presentation and outcomes.
- Primary Gleason grade 4 at the positive margin is associated with metastasis and death among patients with Gleason 7 prostate Cancer undergoing radical prostatectomy.
- PARANEOPLASTIC SARCOID-LIKE REACTIONS AND THE EYE.
- Mortality After Radical Cystectomy: The Impact of Obesity Versus Adiposity After Adjusting for Skeletal Muscle Wasting.
- Oncologic outcomes following surgical resection of Renal cell carcinoma with inferior vena caval thrombus extending above the hepatic veins: a contemporary multicenter...
- Reply to Aaron M. Potretzke, Jeffrey A. Larson and Sam B. Bhayani's Letter to the Editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partia...
- Reply to Homayoun Zargar, Rafael F. Coelho and Jihad H. Kaouk's Letter to the Editor re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of Partial Ne...
- Perioperative Blood Transfusion and Radical Cystectomy: Does Timing of Transfusion Affect Bladder Cancer Mortality?
- Gleason grading after neoadjuvant hormonal therapy retains prognostic value for systemic progression following radical Prostatectomy.
- Diabetes Mellitus is Independently Associated with an Increased Risk of Mortality Among Clear Cell Renal Cell Carcinoma Patients.
- Sarcopenia in patients with Bladder cancer undergoing radical cystectomy: Impact on cancer-specific and all-cause mortality.
- Late recurrence after radical cystectomy: patterns, risk factors and outcomes.
- Predicting Renal Cryoablation Complications: New Risk Score Based on Tumor Size and Location and Patient History.
- Cancer-specific mortality following radical cystectomy for Bladder cancer with lymph node involvement: impact of pathologic disease features and adjuvant chemotherapy.
- ABLATE: A Renal Ablation Planning Algorithm.
- Blood type, lymphadenectomy and Blood transfusion predict venous thromboembolic events following radical prostatectomy with pelvic lymphadenectomy.
- Pretreatment Neutrophil-to-Lymphocyte Ratio Is Associated with Advanced Pathologic Tumor Stage and Increased Cancer-specific Mortality Among Patients with Urothelial C...
- Adjuvant chemotherapy is associated with decreased mortality after radical cystectomy for locally advanced Bladder cancer.
- The association of tumor volume with mortality following radical Prostatectomy.
- The impact of histology on survival for patients with metastatic Renal cell carcinoma undergoing cytoreductive nephrectomy.
- Expression of cyclin d1 and its association with disease characteristics in Bladder cancer.
- Gender-specific survival following radical cystectomy for pT4 Bladder cancer.
- Association between neuraxial analgesia, Cancer progression, and mortality after radical prostatectomy: a large, retrospective matched cohort study.
- Gender-specific Differences in Clinicopathologic Outcomes Following Radical Cystectomy: An International Multi-institutional Study of More Than 8000 Patients.
- The SPARC Score: A Multifactorial Outcome Prediction Model for Patients Undergoing Radical Cystectomy for Bladder Cancer.
- Preoperative estimated glomerular filtration rate predicts overall mortality in patients undergoing radical Prostatectomy.
- Outcome of patients with micropapillary urothelial carcinoma following radical cystectomy: ERBB2 (HER2) amplification identifies patients with poor outcome.
- Perioperative Outcomes Following Surgical Resection of Renal Cell Carcinoma with Inferior Vena Cava Thrombus Extending Above the Hepatic Veins: A Contemporary Multicen...
- The impact of perioperative Blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC).
- Urothelial Carcinoma Involving the Prostate: the Association of Revised Tumor Stage and Coexistent Bladder Cancer with Survival Following Radical Cystectomy.
- Conditional Survival After Radical Cystectomy for Bladder Cancer: Evidence for a Patient Changing Risk Profile over Time.
- Association of T-cell co-regulatory protein expression with clinical outcomes following radical cystectomy for urothelial carcinoma of the Bladder.
- Impact of Perioperative Blood Transfusion on the Outcome of Patients undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder.
- Long-Term Renal Function Outcomes After Radical Cystectomy.
- Comprehensive handbook for developing a Bladder cancer cystectomy database.
- Ultrasound-Guided Transhepatic Radiofrequency Ablation of Renal Tumors: A Safe and Effective Approach.
- The impact of histology on clinicopathologic outcomes for patients with Renal cell carcinoma and venous tumor thrombus: a matched cohort analysis.
- Hospitalization costs for radical Prostatectomy attributable to robotic surgery.
- Eligibility for neoadjuvant/adjuvant cisplatin-based chemotherapy among radical cystectomy patients.
- The Impact of Histological Reclassification During Pathology Re-Review: Evidence of a Will Rogers Effect in Bladder Cancer?
- Risk Stratification of Patients with Extraprostatic Extension and Negative Lymph Nodes at Radical Prostatectomy: Identifying Optimal Candidates for Adjuvant Therapy.
- The impact of clinical stage on prostate Cancer survival following radical prostatectomy.
- Outcomes following radical cystectomy for nested variant of urothelial carcinoma: a matched cohort analysis.
- Practice-setting and surgeon characteristics heavily influence the decision to perform partial nephrectomy among American Urologic Association surgeons.
- Population-based trends in urinary diversion among patients undergoing radical cystectomy for Bladder cancer.
- A novel grading system for clear cell Renal cell carcinoma incorporating tumor necrosis.
- Iatrogenic splenectomy during nephrectomy for Renal tumors.
- Percutaneous Ablation of Renal Masses Measuring 3.0 cm and Smaller: Comparative Local Control and Complications After Radiofrequency Ablation and Cryoablation.
- Disparities in access to hospitals with robotic surgery for patients with prostate Cancer undergoing radical prostatectomy.
- Association of Microvascular and Capillary-Lymphatic Invasion with Outcome for Patients with Renal Cell Carcinoma.
- The Impact of Perioperative Blood Transfusion on Cancer Recurrence and Survival Following Radical Cystectomy.
- Comparative Performance of Comorbidity Indices for Estimating Perioperative and 5-Year All-Cause Mortality Following Radical Cystectomy for Bladder Cancer.
- The Effect of Benign Lower Urinary Tract Symptoms on Subsequent Prostate Cancer Testing and Diagnosis.
- Usefulness of R.e.N.a.L. Nephrometry scoring system for predicting outcomes and complications of percutaneous ablation of 751 Renal tumors.
- Clinical implementation of quality of life instruments and prediction tools for localized prostate Cancer: results from a national survey of radiation oncologists and ...
- Overall Survival and Development of Stage IV Chronic Kidney Disease in Patients Undergoing Partial and Radical Nephrectomy for Benign Renal Tumors.
- Interaction of adjuvant androgen deprivation therapy with patient comorbidity status on overall survival after radical prostatectomy for high-risk prostate Cancer.
- Natural history of biochemical recurrence after radical Prostatectomy with adjuvant radiation therapy.
- Prognostic Significance of Measured Depth of Invasion of Urothelial Carcinoma of the Bladder Compared to the 2010 American Joint Committee on Cancer pT2 and pT3 Classi...
- Percutaneous Renal cryoablation following partial nephrectomy: technical feasibility, complications and outcomes.
- Does partial cystectomy compromise oncologic outcomes for patients with Bladder cancer compared to radical cystectomy? A matched case-control analysis.
- Trends in Minimally Invasive Surgery for the Kidney and Prostate-When are You Doing the Patient a Disservice by Not Referring?
- The Impact of Squamous and Glandular Differentiation on Survival After Radical Cystectomy for Urothelial Carcinoma.
- Comparative Effectiveness for Survival and Renal Function of Partial and Radical Nephrectomy for Localized Renal Tumors: A Systematic Review and Meta-Analysis.
- The Implications of Hospital Acquired Adverse Events on Mortality, Length of Stay and Costs for Patients Undergoing Radical Cystectomy for Bladder Cancer.
- Partial nephrectomy for Renal masses ???7???cm: technical, oncological and functional outcomes.
- HIGH GRADE URETEROSCOPIC BIOPSY IS ASSOCIATED WITH ADVANCED PATHOLOGY OF UPPER Tract UROTHELIAL CARCINOMA TUMORS AT DEFINITIVE SURGICAL RESECTION.
- A critical analysis of the long-term impact of radical prostatectomy on Cancer control and function outcomes.
- Renal function outcomes in patients treated with partial nephrectomy versus percutaneous ablation for renal tumors in a solitary Kidney.
- Contemporary trends in nephrectomy for Renal cell carcinoma in the United States: results from a population based cohort.
- Detection of Asymptomatic Recurrence During Routine Oncological Followup After Radical Cystectomy is Associated With Improved Patient Survival.
- Complications following 573 Percutaneous Renal Radiofrequency and Cryoablation Procedures.
- A multidisciplinary evaluation of inter-reviewer agreement of the nephrometry score and the prediction of long-term outcomes.
- The androgen receptor and stem cell pathways in prostate and Bladder cancers (Review).
- Multi-institutional validation of the ability of preoperative Hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma.
- Outcomes and Clinicopathologic Variables Associated With Late Recurrence After Nephrectomy for Localized Renal Cell Carcinoma.
- Risk Factors and Outcomes of Urethral Recurrence Following Radical Cystectomy.
- Survival after complete surgical resection of multiple metastases from Renal cell carcinoma.
- Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate Cancer.
- Postoperative Intravesical Therapy to Prevent Bladder Tumor Recurrence: Are We Ready to Listen Yet?
- Dynamic prediction of metastases after radical prostatectomy for prostate Cancer.
- Routine Adrenalectomy in Patients with Locally Advanced Renal Cell Cancer Does Not Offer Oncologic Benefit and Places a Significant Portion of Patients at Risk for an ...
- Routine adRenalectomy is unnecessary during surgery for large and/or upper pole Renal tumors when the adRenal gland is radiographically normal.
- Anatomic features of enhancing Renal masses predict malignant and high-grade pathology: a preoperative nomogram using the Renal Nephrometry score.
- Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma.
- Comparison of cold and warm ischemia during partial nephrectomy in 660 solitary Kidneys reveals predominant role of nonmodifiable factors in determining ultimate renal...
Schools
Harvard Medical School
Med College Va
New YorkPresbyterianWeill Cornell
Procedures Preformed
- AdRenalectomy
- Cystectomy
- Cystourethroscopy and TransUrethral Resection of Bladder Neck
- Kidney and Ureter Removal
- View All
Conditions Treated
- Bladder Cancer
- Bladder Infection
- Bladder Stones
- Blood in Urine (Hematuria)
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- Young Urologist of the Year
- AUA-EAU Academic Exchange Program Scholar
- Teacher of the Year
- Fellow (FACS)
Education
-
New York Presbyterian Hospital -
Harvard Medical School
Hospital
-
Mayo Clinic - Rochester, Minnesota
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1942313432 |
| Last Name Of The Provider | BOORJIAN |
| First Name Of The Provider | STEPHEN |
| View All |
Similar Doctors
|
|
Dr. Rodney H. Breau, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Igor Frank, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mitra R. De Cogain, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ilya J. Sobol, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alonso Carrasco Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Boris Gershman, MD |
|
|
Dr. Kelly L. McAlvany, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher Bayne, MD |
|
|
Dr. Landon W. Trost, MD |
|
|
Dr. Matthew J. Ziegelmann, MD
This Doctor is OpenDoctor Recommended.
|